Genpharmasec Rights Issue 2024 vs Skipper Rights Issue 2024

Comparison between Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024. Genpharmasec Rights Issue 2024 is listed on BSE while Skipper Rights Issue 2024 is listed on BSE, NSE.

 Genpharmasec LimitedSkipper Ltd
LogoGenpharmasec Rights Issue 2024 LogoSkipper Rights Issue  2024 Logo
Listing AtBSEBSE, NSE
Terms of Payment

Full amount of Rs.1.75 per Equity Share is payable on application.

Issue Price of Rs.194 is to be paid as Rs. 48.50 on Application and Rs.145.50 on upto three Additonal Calls as may be decided by the Board/Rights Issue Committee.

Entitlement1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date1 Rights Equity Share(s) for every 10 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarPurva Sharegistry (India) Pvt.Ltd.Maheshwari Datamatics Pvt.Ltd.
Lead ManagersVC Corporate Advisors Pvt.Ltd.

Rights Issue Size and Price

The issue size of Genpharmasec Rights Issue 2024 rights issue is ₹48.45 Crores, whereas Skipper Rights Issue 2024 rights issue size is ₹199.18 Crores.

 Genpharmasec LimitedSkipper Ltd
Issue Size27,68,59,850 shares1,02,67,021 shares
Issue Size (Amount)₹48.45 Crores₹199.18 Crores
Issue Price₹1.75 per share₹194 per share
Face Value₹1 per share₹1 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Genpharmasec Rights Issue 2024 is Jan 09, 2024 while record date of Skipper Rights Issue 2024 is Jan 12, 2024.

 Genpharmasec LimitedSkipper Ltd
Record DateJan 09, 2024Jan 12, 2024
Credit of Rights Entitlements
Bid/Offer Opens OnJan 23, 2024Jan 30, 2024
Renunciation of Rights EntitlementsFeb 02, 2024Feb 05, 2024
Bid/Offer Closes OnFeb 13, 2024Feb 08, 2024
Deemed Date of AllotmentFeb 16, 2024Feb 15, 2024
Credit DateFeb 21, 2024Feb 16, 2024
Listing DateFeb 26, 2024Feb 19, 2024

Financials details

Comparison of Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Genpharmasec LimitedSkipper Ltd
Financial

Genpharmasec Limited Financial Information (Restated)

Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets19.8821.6527.82
Revenue25.6227.4121.64
Profit After Tax1.12-0.211.26
Net Worth29.9128.7828.99
Reserves and Surplus28.7828.99
Total Borrowing3.08
Amount in ₹ Crore

Skipper Ltd Financial Information (Restated Consolidated)

Skipper Ltd's revenue increased by 16.04% and profit after tax (PAT) rose by 41.43% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets2,222.642,083.951,919.27
Revenue1,985.621,711.091,585.53
Profit After Tax35.5725.1521.43
Net Worth767.41732.13707.84
Total Borrowing484.02566.65438.55
Amount in ₹ Crore

Compare with others

Compare:

Genpharmasec Rights Issue 2024 Vs Skipper Rights Issue 2024